Trial intelligence / Profile preview

Randomized controlled trial of botulinum toxin type A injection into the tensor fasciae latae for iliotibial band syndrome

MOH_2018-04-16_002175Phase 3Not yet recruiting

Sponsor
ד"ר טל פרנקל רוטנברג
Start
Mar 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised trial in iliotibial band syndrome (ITBS) comparing Dysport injection arm with Saline placebo injection arm (2 arms). Planned start Mar 2018; status: not yet recruiting.

02

Drugs

botulinum toxin type A
03

Conditions

iliotibial band syndrome (ITBS)

Beyond the preview

Go deeper on MOH_2018-04-16_002175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2018-04-16_002175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call